NCT05988086

Double Closure of Nasal Layer in Alveolar Cleft Grafting

Name: Clinical Trial NCT05988086
Creator: Tanta University
Keywords: Alveolar Cleft, platelet rich fibrin, procedure, clinical trial, Egypt

Evaluation of Using Platelet Rich Fibrin Versus Collagen Membrane for Enhancing Healing of Secondary Grafted Alveolar Cleft

Tanta University·ClinicalTrials.gov·procedureEnrolling by invitation

View on ClinicalTrials.gov →

Study focus

Disease/Condition: Alveolar Cleft
Drug/Device/Intervention: platelet rich fibrin
Study type: Interventional
Intervention type: procedure

Sponsor & location

Primary sponsor: Tanta University
Location: Tanta, Egypt

Timeline & enrollment

Phase: N/A
Start date: Oct 10, 2022
End date: Sep 30, 2023
Enrollment: 24 participants

Primary outcome

visual analogue scale,inflammation score scale,density of bone

Summary

The aim of this prospective study is to evaluate both clinically and radiologically the efficacy of using autologous platelets rich fibrin versus collagen membrane for nasal layer closure in secondary alveolar cleft repair.

ICD-10 classifications

Cleft palateCleft palate, unspecifiedCleft soft palateOther branchial cleft malformationsCleft uvula

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT05988086
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT05988086 through Pure Global AI's free database. This phase not specified trial is sponsored by Tanta University and is currently Enrolling by invitation. The study focuses on Alveolar Cleft. Target enrollment is 24 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.